Journals / Turkish Journal of Obstetrics and Gynecology / 2021 / Cilt: 18 - Sayı: 3

Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19

COVID-19’lu gebe kadınlarda intrauterin büyüme geriliği ve preterm erken membran rüptürünün sıklığı: Bir meta-analiz

Pages
236–244
Publication Date
2022-11-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, well-designed, large-scale and multicenter clinical studies are required to improve and validate these results

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The impact of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pregnancy has yet to be determined.
📊
Key Findings & Data:Some studies indicate that SARSCoV-2 infection may be associated with a higher risk of adverse outcomes in pregnant women.
💡
Conclusion & Impact:However, well-designed, large-scale and multicenter clinical studies are required to improve and validate these results
🔬Design:Lab & Field Experiment
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

The impact of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in pregnancy has yet to be determined. Some studies indicate that SARSCoV-2 infection may be associated with a higher risk of adverse outcomes in pregnant women. Here, we performed a meta-analysis to estimate the frequency of intrauterine growth restriction (IUGR) and preterm premature rupture of the membranes (PPROM) in pregnant women with Coronavirus disease-2019 (COVID-19). A comprehensive search was performed in various databases, such as PubMed, Scopus, SciELO, MedRxiv, and Web of Science, to find all relevant studies published before 10 February 2021. Cross-sectional and consecutive case series reporting the pregnancy outcomes of COVID-19 were included. A total of 24 studies, including 8 studies on IUGR and 16 studies on PPROM, were selected. Pooled data showed that the frequencies of IUGR and PPROM in pregnant women with COVID-19 were 2.6% and 9.9%, respectively. Analyses stratified by ethnicity showed that the frequencies of IUGR in Asian and Caucasian COVID-19-infected pregnant women were 2.9% and 2.0%, respectively. Moreover, the frequencies of PPROM in Asian and Caucasian COVID-19-infected pregnant women were 10.2% and 5.8%, respectively. This meta-analysis showed that the frequencies of IUGR and PPROM in COVID-19-infected pregnant women were 2.6% and 9.9%, respectively. However, well-designed, large-scale and multicenter clinical studies are required to improve and validate these results

Özet

Şiddetli akut solunum sendromu-koronavirüs-2’nin (SARS-CoV-2) gebelikteki etkisi henüz bilinmemektedir. Bazı çalışmalar, SARS-CoV-2 enfeksiyonunun hamile kadınlarda artmış olumsuz sonlanım riski ile ilişkili olabileceğini göstermiştir. Burada, Koronavirüs hastalığı-2019’lu (COVID-19) hamile kadınlarda intrauterin büyüme geriliği (İUGG) ve preterm erken membran rüptürü (PERM) sıklığını tahmin etmek için bir meta-analiz gerçekleştirdik. 10 Şubat 2021’den önce yayınlanan tüm ilgili çalışmaları bulmak için PubMed, Scopus, SciELO, MedRxiv ve Web of Science’da kapsamlı bir arama yapıldı. Gebe kadınlarda COVID-19’un gebelik sonuçlarını bildiren kesitsel çalışmalar ve ardışık olgu serileri dahil edildi. İUGG üzerine 8 çalışma ve PERM üzerine 16 çalışma olmak üzere toplam 24 çalışma seçildi. Havuzlanmış veriler, COVID-19’lu enfekte kadınlarda İUGG ve PERM sıklığının sırasıyla %2,6 ve %9,9 olduğunu göstermiştir. Etnik kökene göre tabakalı analizler, Asyalı ve Kafkasyalı enfekte hamile kadınlarda İUGG sıklığının sırasıyla %2,9 ve %2,0 olduğunu göstermiştir. Ayrıca, Asyalı ve Kafkasyalı enfekte gebelerde PERM sıklığı sırasıyla %10,2 ve %5,8 idi. Bu meta-analiz, COVID-19 ile enfekte hamile kadınlarda İUGG ve PERM sıklığının sırasıyla %2,6 ve %9,9 olduğunu göstermiştir. Bununla birlikte, bu sonuçları iyileştirmek ve doğrulamak için iyi tasarlanmış, büyük ölçekli ve çok merkezli klinik çalışmalara ihtiyaç vardır.

🔖

Cite This Article

Karimi-Zarchi, M., Dastgheib, S. A., Bahrami, R., Javaheri, A., Noorishadkam, M., Neamatzadeh, H., Schwartz, D. A., Ferdosian, F., Mirjalili, S. R. (2022). Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19. Turkish Journal of Obstetrics and Gynecology, Cilt: 18 - Sayı: 3, 236–244. https://ajindex.com/articles/612918

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, Abbasi H, Mirjalili SR, Behforouz A, et al. Vertical transmission of coronavirus disease 19 (covid-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol 2020;39:246-50
  2. Mirjalili H, Dastgheib SA, Shaker SH, Bahrami R, Mazaheri M, SadrBafghi SMH, et al. Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis. J Diabetes Metab Disord 2021;20:905-17
  3. Racicot K, Mor G. Risks associated with viral infections during pregnancy. J Clin Invest 2017;127:1591-9
  4. Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G. Viral infections during pregnancy. Am J Reprod Immunol 2015;73:199- 213
  5. Noorishadkam M, Lookzadeh MH, Mazaheri M, Mirjalili SR, Bahrami R, Asadian F, et al. Coronavirus disease 2019 (COVID-19) and late pregnancy loss in infected pregnant women: a mini review. World J Peri Neonatol 2020;2:67-70
  6. Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev 2021;101:303-18
  7. Lambelet V, Vouga M, Pomar L, Favre G, Gerbier E, Panchaud A, et al. SARS-CoV-2 in the context of past coronaviruses epidemics: Consideration for prenatal care. Prenat Diagn 2020;40:1641-54
  8. Chen S, Liao E, Cao D, Gao Y, Sun G, Shao Y. Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia. J Med Virol 2020;92:1556-61
  9. Abou Ghayda R, Li H, Lee KH, Lee HW, Hong SH, Kwak M, et al. COVID-19 and adverse pregnancy outcome: a systematic review of 104 cases. J Clin Med 2020;9:3441
  10. Seymen CM. Being pregnant in the COVID-19 pandemic: effects on the placenta in all aspects. J Med Virol 2021;93:2769-73
  11. Biasucci G, Cannalire G, Raymond A, Capra ME, Benenati B, Vadacca G, et al. Safe perinatal management of neonates born to SARSCoV-2 positive mothers at the epicenter of the italian epidemic. Front Pediatr 2020;8:565522. doi:10.3389/fped.2020.565522 12. Bahrami R, Dastgheib SA, Niktabar SM, Amooee A, Lookzadeh MH, Mirjalili SR, et al. Association of BMP4 rs17563 polymorphism with nonsyndromic cleft lip with or without cleft palate risk: literature review and comprehensive meta-analysis. Fetal Pediatr Pathol 2021;40:305-19
  12. Delahoy MJ, Whitaker M, O’Halloran A, Chai SJ, Kirley PD, Alden N, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — CO